NEW YORK, July 7, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding JPMorgan Chase & Co. (NYSE: JPM), Leju Holdings Limited (NYSE: LEJU), Gramercy Property Trust Inc. (NYSE: GPT), The Carlyle Group LP (NASDAQ: CG) and Credit Acceptance Corp. (NASDAQ: CACC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4504-100free.
--
JPMorgan Chase & Co. Analyst Notes
On July 1, 2014, JPMorgan Chase & Co. (JPMorgan Chase) announced that in accordance with the terms of the outstanding warrants to purchase common stock of the Company, it will reduce the warrant exercise price from $42.42 per share to c.$42.41 per share, effective as of close of business on July 3, 2014. According to the Company, the adjustment resulted from the Company Board of Director's declaration on May 20, 2014, of a quarterly dividend of $0.40 per share on the outstanding shares of the Company's common stock, payable on July 31, 2014, to stockholders of record as of the close of business on July 3, 2014. JPMorgan Chase further stated that the dividend declaration did not result in a change in the Warrant Share Number. The full analyst notes on JPMorgan Chase are available to download free of charge at:
http://www.analystsreview.com/Jul-07-2014/JPM/report.pdf
--
Leju Holdings Limited Analyst Notes
On July 2, 2014, Leju Holdings Limited's (Leju) stock increased by 1.27%, ending at $11.19. For the past one-month trading period, Company's stock went up by 0.81% compared to the Dow Jones Industrial Average's gain of 1.38% during the same trading period. The full analyst notes on Leju are available to download free of charge at:
http://www.analystsreview.com/Jul-07-2014/LEJU/report.pdf
--
Gramercy Property Trust Inc. Analyst Notes
On July 1, 2014, Gramercy Property Trust Inc. (Gramercy Property Trust) announced that the Company has closed the acquisition of an R&D flex facility located in Malvern, Pennsylvania (Philadelphia MSA). According to the Company, the facility measures approximately 191,000 sq. ft. and is 100% leased through March 2030 to a leading healthcare diagnostics company. Additionally, the Company stated that the facility was acquired for a purchase price of approximately $28.4 million in cash. The full analyst notes on Gramercy Property Trust are available to download free of charge at:
http://www.analystsreview.com/Jul-07-2014/GPT/report.pdf
--
The Carlyle Group LP Analyst Notes
On June 30, 2014, The Carlyle Group LP (The Carlyle Group) announced that the Company has completed the acquisition of Ortho-Clinical Diagnostics, Inc. (OCD), a former subsidiary of Johnson & Johnson, for approximately $4 billion. Commenting on the acquisition, Company Managing Director, Stephen H. Wise, stated, "As a free-standing company with new leadership and accelerated investment in R&D, OCD is well positioned to tap into rising demand for sophisticated medical diagnostic products and services worldwide. We have assembled a remarkable senior management team, led by Dr. Martin D. Madaus, and we look forward to partnering with him in the years to come." The full analyst notes on The Carlyle Group are available to download free of charge at:
http://www.analystsreview.com/Jul-07-2014/CG/report.pdf
--
Credit Acceptance Corp. Analyst Notes
On June 23, 2014, Credit Acceptance Corp. (Credit Acceptance) announced that the Company has extended the maturity of its credit facility with a commercial bank syndicate. According to the Company, the date has been extended from June 23, 2016 to June 23, 2017. Additionally, the Company stated that although the maturity date has been extended, there were no material changes to the terms of the facility. The full analyst notes on Credit Acceptance are available to download free of charge at:
http://www.analystsreview.com/Jul-07-2014/CACC/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
